相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study
Wang-Zhong Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Locoregional Radiation Therapy for De Novo Metastatic Nasopharyngeal Cancer: One Size Fits All?
Lachlan McDowell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma
Wang-Zhong Li et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study
Xue-Song Sun et al.
CANCER COMMUNICATIONS (2020)
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma A Multicenter Phase 3 Randomized Clinical Trial
Rui You et al.
JAMA ONCOLOGY (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
Fangzheng Wang et al.
JOURNAL OF CANCER (2020)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinoma
Xue-Song Sun et al.
ORAL ONCOLOGY (2019)
Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives
Jinyi Lang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy
Xue-Song Sun et al.
BMC CANCER (2019)
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Xin-Ran Tang et al.
LANCET ONCOLOGY (2018)
Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
Tapesh Bhattacharyya et al.
JOURNAL OF ONCOLOGY (2018)
Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment
Xiong Zou et al.
EUROPEAN JOURNAL OF CANCER (2017)
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases
Chiachien Jake Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study
Chi-Hao Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy
Chad G. Rusthoven et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Nasopharyngeal carcinoma incidence and mortality in China, 2013
Kuang-Rong Wei et al.
CHINESE JOURNAL OF CANCER (2017)
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
Encouse B. Golden et al.
LANCET ONCOLOGY (2015)
Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system
Lu-Jun Shen et al.
CHINESE JOURNAL OF CANCER (2015)
Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013
Jinyi Lang et al.
FUTURE ONCOLOGY (2014)
Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels
Wen-Yi Wang et al.
CANCER (2013)
Baseline Serum Lactate Dehydrogenase Levels for Patients Treated With Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Predictor of Poor Prognosis and Subsequent Liver Metastasis
Guan-Qun Zhou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Plasma Epstein-Barr Virus DNA Level Strongly Predicts Survival in Metastatic/Recurrent Nasopharyngeal Carcinoma Treated With Palliative Chemotherapy
Xin An et al.
CANCER (2011)
Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
Wen-Yi Wang et al.
CLINICAL CANCER RESEARCH (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
分享论文
